7731—53

MARX Biotech Co Ltd

Miscellaneous Specialty RetailersVerified

Score breakdown

Sentiment+15Risk penalty-3Missing signals-3

Quality breakdown

Key fields100Profile38Conclusion82AI synthesis40Observations3

MARX Biotech Co Ltd (7731.TWO) is currently classified as Retailers within Miscellaneous Specialty Retailers (Consumer Cyclicals). Classification confidence: 0.92 (verified market data). Capital structure on the latest snapshot: total assets 731,196,000 TWD, total equity 251,248,000, short-term debt 0, long-term debt 277,318,000. Net cash position is approximately -277,318,000 TWD. Profitability profile: revenue 618,226,000, gross profit 430,067,000, operating income -85,002,000, net income -96,825,000. Return on equity ~-38.5%. Return on assets ~-13.2%. Operating-cash-flow to net-income ratio is 1.11. Risk profile from automated assessment: liquidity risk medium, dilution risk low. Flags: Net cash is negative after subtracting total debt..

30-day price · 7731+1.28 (+25.4%)

Low$4.91High$8.60Close$6.32As of7 May, 00:00 UTC

Profile

CompanyMARX Biotech Co Ltd

Ticker7731.TWO

SectorConsumer Cyclicals

BusinessRetailers

Industry groupRetailers

IndustryMiscellaneous Specialty Retailers

AI analysis

Business. MARX Biotech Co Ltd is classified under Consumer Cyclicals / Miscellaneous Specialty Retailers and appears not currently profitable on the latest normalized snapshot.

Classification. Classification confidence is 0.92 based on verified market data; matched terms: Miscellaneous Specialty Retailers, Retailers, Consumer Cyclicals.

Key takeaways

Return on equity is about -38.5%.
Debt to equity is about 1.1x.

Financial snapshot

PeriodHA-latest

CurrencyTWD

Revenue$618.2M

Gross profit$430.1M

Operating income-$85.0M

Net income-$96.8M

R&D—

SG&A—

D&A—

SBC—

Operating cash flow-$107.2M

CapEx-$218.6M

Free cash flow-$297.4M

Total assets$731.2M

Total liabilities$479.9M

Total equity$251.2M

Cash & equivalents—

Long-term debt$277.3M

Annual history (last 5)

PeriodRevenueOp IncomeNet IncomeFCF

FY0$618.2M-$85.0M-$96.8M-$297.4M

FY-1$289.9M-$16.9M-$12.9M-$10.1M

FY-2$110.6M$898.0k$2.8M$4.1M

FY-3$97.6M$15.1M$13.8M$15.0M

FY-4————

PeriodGross %Op %Net %FCF %

FY0————

FY-1————

FY-2————

FY-3————

FY-4————

PeriodAssetsEquityCashDebt

FY0$731.2M$251.2M——

FY-1$394.8M$293.0M——

FY-2$103.2M$60.7M——

FY-3$91.1M$65.6M——

FY-4————

PeriodOCFCapExFCFSBC

FY0-$107.2M-$218.6M-$297.4M—

FY-1-$14.1M-$1.7M-$10.1M—

FY-2$11.4M-$696.0k$4.1M—

FY-3-$16.7M-$47.0k$15.0M—

FY-4————

Quarterly history (last 4)

PeriodRevenueOp IncomeNet IncomeFCF

FQ0————

FQ-1————

FQ-2————

FQ-3————

FQ-4————

FQ-5————

FQ-6————

FQ-7————

PeriodGross %Op %Net %FCF %

FQ0————

FQ-1————

FQ-2————

FQ-3————

FQ-4————

FQ-5————

FQ-6————

FQ-7————

PeriodAssetsEquityCashDebt

FQ0————

FQ-1————

FQ-2————

FQ-3————

FQ-4————

FQ-5————

FQ-6————

FQ-7————

PeriodOCFCapExFCFSBC

FQ0————

FQ-1————

FQ-2————

FQ-3————

FQ-4————

FQ-5————

FQ-6————

FQ-7————

Valuation

Market price—

Market cap—

Enterprise value—

P/E—

Reported non-GAAP P/E—

EV/Revenue—

EV/Op income—

EV/OCF—

P/B—

P/Tangible book—

Tangible book$251.2M

Net cash-$277.3M

Current ratio1.3

Debt/Equity1.1

ROA-13.2%

ROE-38.5%

Cash conversion1.1%

CapEx/Revenue-35.4%

SBC/Revenue—

Asset intensity—

Dilution ratio0.0%

Risk assessment

Dilution riskLow

Liquidity riskMedium

Net cash is negative after subtracting total debt.

Industry benchmarks

Activity: Retailers · cohort 2 companies

Metric7731Activity

Op margin-13.7%20.7% medp25 18.7% · p75 22.8%bottom quartile

Net margin-15.7%15.6% medp25 13.4% · p75 17.7%bottom quartile

Gross margin69.6%31.0% medp25 19.6% · p75 40.5%top quartile

R&D / revenue—0.4% medp25 0.4% · p75 0.4%

CapEx / revenue-35.4%4.6% medp25 3.2% · p75 5.9%bottom quartile

Debt / equity110.0%39.3% medp25 19.7% · p75 97.3%top quartile

Source data

Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.

Company fundamentalsperiod FQ-7 · history via verified-market-data

no public URL

2026-05-06 05:50 UTC#d8a4bd28

Source: analysis-pipeline (hybrid)Generated: 2026-05-06 05:59 UTCJob: d11cc077